Can I Start Mounjaro at 5mg — or Does the Dose Schedule Matter?

You've been told the starter pen 'doesn't do anything', here's why that's not the full picture

It's a question our prescribers hear most weeks: someone has read online that 2.5mg is too low to cause meaningful weight loss, so can they simply begin at 5mg and get results faster? The instinct is understandable. But the 2.5mg starting dose isn't a therapeutic staging post, it's a tolerability measure. Tirzepatide, the active ingredient in Mounjaro, slows the movement of food through your stomach and acts on two gut-hormone receptors simultaneously. That dual action is part of what makes it effective, but it's also why your digestive system needs time to adjust. Beginning at 5mg compresses that adjustment into a sharper curve: nausea, vomiting and diarrhoea become more likely, and more severe. The NHS tirzepatide information page is clear that treatment starts at 2.5mg weekly for four weeks before any increase is considered. That four-week window isn't arbitrary, it's the period in which most people move through the worst of the early GI effects. Skipping it doesn't remove those effects; it concentrates them. For most people, the 2.5mg pen does produce some early change in appetite. If you're weighing up whether starting on 5mg tirzepatide is a reasonable option, weight loss at this stage tends to be modest regardless, but the system is already responding. Patience here is genuinely clinical advice, not a commercial one.

What the licensed schedule actually looks like from 5mg onwards

Once a prescriber confirms you've tolerated 2.5mg well after four weeks, the next step is the 5mg pen, and this is where many people notice a more tangible shift. From 5mg, the schedule continues upward in 4-week increments through 7.5mg, 10mg, 12.5mg and up to a maximum of 15mg, though not everyone needs or reaches the highest dose. Each increase is conditional on how the previous dose was tolerated. If you're finding 2.5mg difficult, a prescriber may choose to stay at that level for longer rather than escalate. If someone genuinely cannot tolerate 2.5mg at all, the conversation is about whether Mounjaro is the right treatment, not about jumping ahead. The question of starting at 7.5mg comes up for similar reasons, and the clinical answer follows the same logic. The SmPC is explicit that dose increases should happen no sooner than four-week intervals, and NICE's appraisal of tirzepatide, TA1026, is built around this approved schedule. If after six months at the highest tolerated dose less than 5% of body weight has been lost, the guidance recommends reviewing whether treatment should continue. Worth noting: pricing across doses is worth understanding before you start, and the context behind Mounjaro's UK pricing helps explain why costs differ between providers and dose steps.

Situations where a prescriber might consider a different starting point, and the limits of that

There is one category of person for whom starting Mounjaro at something other than the very beginning is clinically reasonable: someone transferring from another GLP-1 medicine, such as semaglutide, who is already tolerating that treatment well. In those cases, a prescriber may assess whether beginning further along the Mounjaro titration schedule is appropriate. But this is a clinical judgement made with evidence of the patient's current treatment, current dose and tolerance history, not a shortcut available on request. It applies to transfers, not to first-time users. If you've seen providers online advertising the option to start at 5mg without any transfer context, that warrants scrutiny. A licensed prescriber working within the approved schedule will always begin the conversation at 2.5mg for a new patient and build from there. The broader picture of how Mounjaro works as a treatment, including what the full titration process involves, is worth reading before your consultation. And if you're specifically interested in tirzepatide from a weight-loss angle, the question of starting at 5mg for weight loss is addressed in more detail separately. A prescriber at our clinical team reviews every consultation personally before any prescription is issued.

Starting Mounjaro safely through a regulated UK pharmacy

When you're ready to begin, the process through a regulated online pharmacy doesn't require a GP referral or a waiting list. You complete a clinical consultation, it goes directly to a GPhC-registered Independent Prescriber for same-day review, and if approved, the treatment is dispatched the same day for next-working-day delivery by DPD, in plain unbranded packaging. The key thing: the prescriber decides your starting dose based on your health history, not based on what you've requested. That is the safeguard that makes starting treatment safely possible. If you're unsure whether Mounjaro is right for you, or which medicines are currently available, our treatment consultation page is the right place to start.